Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2009-06-12
2010-10-12
Babic, Christopher M. (Department: 1637)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S975000
Reexamination Certificate
active
07812144
ABSTRACT:
An in vitro method is provided for screening human female subjects to assess their risk of developing cervical carcinoma which comprises screening the subject for expression of mRNA transcripts from the E6 and optionally the L1 gene of human papillomavirus, wherein subjects positive for expression of L1 and/or E6 mRNA are scored as being at risk of developing cervical carcinoma. Kits for carrying out such methods are also provided.
REFERENCES:
patent: 5474796 (1995-12-01), Brennan
patent: 5506105 (1996-04-01), Haydock
patent: 5580970 (1996-12-01), Hendricks et al.
patent: 5639871 (1997-06-01), Bauer et al.
patent: 5654416 (1997-08-01), Cummins et al.
patent: 5750334 (1998-05-01), Cerutti et al.
patent: 6027891 (2000-02-01), Von Knebel-Doberitz et al.
patent: 6027981 (2000-02-01), Wu
patent: 2001/0053519 (2001-12-01), Fodor et al.
patent: 2004/0214302 (2004-10-01), Anthony et al.
patent: 2005/0118568 (2005-06-01), Karlsen
patent: 2005/0244813 (2005-11-01), Karlsen
patent: 2007/0281295 (2007-12-01), Karlsen
patent: 2007/0292841 (2007-12-01), Karlsen
patent: 0 243 221 (1987-10-01), None
patent: 0 402 132 (1990-12-01), None
patent: 0 662 518 (1995-07-01), None
patent: 0 774 518 (1997-05-01), None
patent: WO 90/02821 (1990-03-01), None
patent: WO 91/08312 (1991-06-01), None
patent: WO 94/26934 (1994-11-01), None
patent: WO 99/29890 (1999-06-01), None
patent: WO 00/00638 (2000-01-01), None
patent: WO 01/73135 (2001-11-01), None
patent: WO 02/08460 (2002-01-01), None
patent: WO 03/057914 (2003-07-01), None
patent: WO 03/057927 (2003-07-01), None
Karlsen et al. (J Clin Microbiol. Sep. 1996;34(9):2095-100).
Stratagene (“Gene Characterization Kits” 1988).
NCBI (Accession No. X74479; Aug. 22, 1993).
NCBI (Accession No. X74481; Aug. 22, 1993).
NCBI (Accession No. D90400; Apr. 17, 1992).
Arbeit et al. (Am J Pathol. Apr. 1993;142(4):1187-97).
[Author Unknown] http://www.biotech.ist.unige.it/cldb/cl4900.html; web page regarding SiHa cells, May 27, 2004.
In Re DEUEL 34 USPQ 2d 1210 (Fed. Cir. 1995).
Anderson et al., Human papillomavirus and cervical cancer. Clin Microbiol Newslett. Aug. 1, 2002;24(15):113.
Arbeit, J. M. et al., Neuroepithelial Carcinomas in Mice Transgenic with Human Papillomavirus Type 16 E6/E7 ORFs, American Journal of Pathology 1993; 142(4):1187-1197.
Bosch et al., Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference. J Clin Pathol. Mar. 2001;54(3):163-75.
Bosch, F.X. et al., Prevalence of Human papillomavirus in cervical cancer: a worldwide perspective. Journal of the National Cancer Institute Jun. 7, 1995; 87(11):796-802.
Bosch, F. X. et al., The causal relation between human papillomavirus and cervical cancer, J. Clin. Pathol. 2002; 55:244-265.
Buck et al. (1999) Design strategies and performance of custom DNA sequencing primers. Biotechniques. vol. 27, pp. 528-536.
Clifford et al., Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. Jan. 13, 2003;88(1):63-73.
Cornelissen, M.T. et al., Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. Journal of General Virology, Society for General Microbiology, Reading, GB, May 1, 1990; 71(No. Part 5):1243-1249.
Coutlee, F. et al., Detection of transcripts of human papillomaviruses 16 and 18 in Cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization. J. Clin. Micro. 1991; 29:968-974.
Cuschieri et al., Human papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoring. J Med Virol. May 2004;73(1):65-70.
Database, HPV sequence Database, ′Online! 'Los Alamos National Laboratory; Sep. 1997, Los Alomos National Laboratory; “Human papilloma viruses 1997 compendium,” pp. E6-10-E6-24.
Doeberitz, M. New molecular tools for efficient screening of cervical cancer. 2001; 17:123-128.
Duensing et al., Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer. Mar. 20, 2004;109(2):157-62.
Iwasawa, A. et al. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. American Cancer Society 1996; 77(11):2275-2279.
Jeon et al., Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol. May 1995;69(5):2989-97.
Jeon et al., Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis. Proceedings of the National Academy of Sciences of the U.S.; 1995; 92(5):1654-1658.
Karlsen et al., Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. Sep. 1996;34(9):2095-100.
Kado, S. et al., Detection of human papillomavirus in cervical neoplasias using multiple sets of generic polymerase chain reaction primers. Gynecologic Oncology Apr. 2001; 81(1):47-52.
Kievits et al. (1991) NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. Journal of Virological Methods. vol. 35, pp. 273-286.
Klaes et al., Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. Dec. 15, 1999;59(24):6132-6.
Kraus et al., Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones. Br J Cancer. Apr. 5, 2004;90(7):1407-13.
Kraus et al., Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas. J Clin Microbiol. Apr. 2006;44(4):1310-7.
Lanham, S. et al., NPV detection and measurement of HPV-16, telomerase, and survivin transcripts in colposcopy clinic patients. J. Clin. Pathol. 2001; 54:304-308.
Leone et al., Molecular beacon probes combined with amplification by NASBA enable homogeneous, real-time of RNA. Nucleic Acids Research 1998; 26(9):2150-2155.
Lie et al., DNA versus RNA based methods for HPV testing in Norway. Evaluation of Hybrid Capture II and PreTesct HPV-Proofer, a validation study. 21stInternational Papillomavirus Conference, Feb. 20-26, Mexico City, Mexico.
McNicol, P. et al., Expression of human papillomavirus type 16 E6-E7 open reading frame varies, quantitatively in biopsy tissue from different grades of cervical intraepithelial neoplasia. Journal of Clinical Microbiology 1995; 33(5):1169-1173.
Molden et al., Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev. Feb. 2005;14(2):367-72.
Molden et al., Human papillomavirus E6/E7 mRNA expression in women younger than 30 years of age. Gynecol Oncol. Jan. 2006;100(1):95-100. Epub Sep. 8, 2005.
Munoz et al., Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. Aug. 20, 2004;111(2):278-85.
Mu{hacek over (n)}oz, N. Human papillomavirus and cancer: the epidemiological evidence, Journal of Clinical Virology 2000; 19:1-5.
Pim et al., Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene. Jul. 17, 1997;15(3):257-64.
Schneider-Gadicke et al., Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J. Sep. 1986;5(9):2285-92.
Schneider, A. et al., Importance of Human Papillomavirus Detection in Screening, 2001; Deutsches Arzteblatt 2001; Jg. 98, 39:2517-2521, Abstract Only.
Simpkins et al. (Jan. 2000) An RNA transcription-based amplification technique (NASBA) for the detection of viable Salmonella enterica. Letters in Applied Microbiology. vol.
Babic Christopher M.
Norchip A/S
Wolf Greenfield & Sacks P.C.
LandOfFree
Method for detecting human papillomavirus mRNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting human papillomavirus mRNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting human papillomavirus mRNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4241018